Published in J Clin Oncol on September 01, 2003
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer. J Clin Oncol (2010) 1.80
What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer. J Gastrointest Oncol (2012) 0.83
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy. J Surg Oncol (2016) 0.81
Intrahepatic therapy for liver-dominant metastatic colorectal cancer. World J Gastrointest Oncol (2015) 0.81
Is there a new drug beyond floxuridine for intra-arterial hepatic chemotherapy in liver metastases from colorectal cancer? J Clin Oncol (2005) 0.81
The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study. Invest New Drugs (2007) 0.77
Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg (2013) 0.77
What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases? Nat Clin Pract Oncol (2008) 0.77
Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastases. Int J Hepatol (2013) 0.75
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver. Invest New Drugs (2015) 0.75
Treatment Options in Colorectal Liver Metastases: Hepatic Arterial Infusion. Visc Med (2017) 0.75
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet (1987) 4.18
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med (1988) 4.02
Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet (1988) 3.30
Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg (1998) 3.04
Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg (1998) 2.97
Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81
Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60
Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57
Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg (1999) 2.57
Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol (2000) 2.48
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg (2000) 2.43
Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39
Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol (2008) 2.12
One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg (1994) 2.03
Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg (1995) 1.99
Management of 155 patients with benign liver tumours. Br J Surg (2001) 1.97
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol (2002) 1.96
Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg (2000) 1.85
Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J (1989) 1.82
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol (1999) 1.75
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer (2004) 1.75
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol (1993) 1.73
Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg (2001) 1.69
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J (1999) 1.64
Hand-assisted laparoscopic liver resection: lessons from an initial experience. Arch Surg (2000) 1.60
Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem (2000) 1.59
A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer (2001) 1.57
A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg (2000) 1.57
Clear cell papillary carcinoma of the liver: an unusual variant of peripheral cholangiocarcinoma. Hum Pathol (1998) 1.53
Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet (1990) 1.50
FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med (2001) 1.49
Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg (1995) 1.40
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol (2009) 1.39
The Caenorhabditis elegans maternal-effect sterile proteins, MES-2, MES-3, and MES-6, are associated in a complex in embryos. Proc Natl Acad Sci U S A (2001) 1.32
Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR Am J Roentgenol (1997) 1.32
Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery (1998) 1.32
Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. Ann Surg (1989) 1.27
Augmentation of apoptosis and tumor regression by flavopiridol in the presence of CPT-11 in Hct116 colon cancer monolayers and xenografts. Clin Cancer Res (2001) 1.26
Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther (2006) 1.23
Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. J Clin Invest (1997) 1.22
What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg (2001) 1.21
Complete resection of the caudate lobe of the liver: technique and results. Br J Surg (1996) 1.21
Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg (2007) 1.19
Isolated hepatic splenosis: first reported case. HPB Surg (1998) 1.18
Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg (1999) 1.18
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer. Eur Radiol (2011) 1.17
Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J (1989) 1.17
Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc Natl Acad Sci U S A (1999) 1.15
Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology (1996) 1.14
Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes. J Biol Chem (2000) 1.14
Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol (2012) 1.14
A technique for the use of cryosurgery to assist hepatic resection. J Am Coll Surg (1995) 1.13
Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus. J Virol (2001) 1.12
The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol (2003) 1.12
Recent advances in hepatic resection. Semin Surg Oncol (2000) 1.11
Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia (2001) 1.11
Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer (2007) 1.11
Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma. Hum Gene Ther (2001) 1.10
Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR Am J Roentgenol (1998) 1.09
Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg (1995) 1.09
Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med (2001) 1.08
Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg (1997) 1.07
Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg (1998) 1.07
Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann Surg Oncol (1998) 1.06
Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. J Am Coll Surg (2001) 1.06
Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy. Hum Gene Ther (2000) 1.04
Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Ther (2009) 1.04
Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg (2007) 1.03
Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer. J Mol Med (Berl) (2000) 1.03
Radiofrequency ablation in the management of liver metastases from breast cancer. AJR Am J Roentgenol (2007) 1.02
Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses. J Infect Dis (1992) 1.02
Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol (1997) 1.02
Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR Am J Roentgenol (1996) 1.01
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. Ann Surg Oncol (2013) 1.01
Use of preoperative autologous blood donation in liver resections for colorectal metastases. Am J Surg (1998) 1.01
Cachectin/TNF production in experimental burns and Pseudomonas infection. Arch Surg (1988) 1.01
Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses. J Gastrointest Surg (2001) 1.00
Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207). Hum Gene Ther (1999) 1.00
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol (2001) 0.99
Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol (2001) 0.99